Vidwan-ID : 31559



  • Dr Mahesh Radhakrishnan

  • Senior Professor
  • Birla Institute of Technology and Science, Pilani
Publications 2004 - 2019

Publications

  • 193
    Journal Articles
  • 1
    Book Chapter
  • 58
    Conference
    Proceedings
  • 7
    Review
  • 4
    Projects

Citations / H-Index

1614 Citations
23 h-index
1815 Citations

Altmetrics

27
27
33
833
27

Google Scholar

Co-author Network


Expertise

Neurosciences

[I] Drug design & synthesis of; (a) Serotonergic modulators with special emphasis on neurodegenerative disorders (b) Anti-malarial agents [II] Neuro-psychopharmacology; Depression, Anxiety, Alzheimer’s & Parkinson’s Diseases, Cognitive Impairments and Depression Co-morbid with Metabolic Disorders

Personal Information

Dr Mahesh Radhakrishnan

Male
Department of Pharmacy, Birla Institute of Technology & Science, Pilani, Pilani Campus Birla Institute of Technology and Science, Pilani, Vidya Vihar
Pilani, Rajasthan, India - 333031


Experience

  • Senior Professor

    Department of Pharmacy

    Birla Institute of Technology and Science, Pilani

  • Professor

    Department of Pharmacy

    Birla Institute of Technology and Science, Pilani

  • Associate Professor

    Department of Pharmacy

    Birla Institute of Technology & Science, Pilani, Pilani Campus

  • Assistant Professor

    Department of Pharmacy

    Birla Institute of Technology & Science, Pilani, Pilani Campus


Qualification

  • Ph.D.

    Birla Institute of Technology & Science, Pilani, Pilani Campus

  • M. Pharm

    Birla Institute of Technology & Science, Pilani, Pilani Campus


Honours and Awards

2016

Best Poster 1st Presentation Prize

DBT, ICMR and APTI Sponsored National Conference on “Contemporary Technologies in Drug Delivery and Envisaged Future Trends” at Geetanjali Institute of Pharmacy, Geetanjali University, Udaipur, Rajasthan, India.

2014

Best Poster 2nd Presentation Prize

NIPICON International Conference

2014

Best Published Paper Award; Prof. Duggirala Visweswaram & Prof. Sreemantalu Satyanarayana Award (Assoc. of Pharm. Teachers of India Conf. 2014)

Association of Pharmaceutical Teachers of India (APTI)

Read More
2016

Best Poster 1st Presentation Prize

DBT, ICMR and APTI Sponsored National Conference on “Contemporary Technologies in Drug Delivery and Envisaged Future Trends” at Geetanjali Institute of Pharmacy, Geetanjali University, Udaipur, Rajasthan, India.

2014

Best Poster 2nd Presentation Prize

NIPICON International Conference

2014

Best Published Paper Award; Prof. Duggirala Visweswaram & Prof. Sreemantalu Satyanarayana Award (Assoc. of Pharm. Teachers of India Conf. 2014)

Association of Pharmaceutical Teachers of India (APTI)

2013

Best Published Paper Award; NN Dutta Prize (Indian Pharmacology Society Conf. 2013)

Indian Pharmacology Society Conf. 2013

2012

Best Poster 1st Prize

Pharmanext (AIPER)

2012

Best Poster Presentation Prize

Indian Pharmaceutical Association

2012

Best Published Paper Award (Prof. Duggirala Visweswaram & Prof. Sreemantalu Satyanarayana Award )

Association of Pharmaceutical Teachers of India (APTI)

2011

Best Published Paper Award (Prof. Duggirala Visweswaram & Prof. Sreemantalu Satyanarayana Award )

Association of Pharmaceutical Teachers of India (APTI)

2011

Best Poster Presentation 1st Prize

Indian Pharmacological Society International Convention

2011

PC Dandiya Award

Indian Pharmacological Society International Convention

2009

Best Poster Presentation 1st Prize

Association of Pharmaceutical Teachers of India (APTI), Conference

2008

Best Poster Presentation 1st Prize

Indian Pharmacological Society International Convention

2005

Best Paper Published

Indian Pharmaceutical Congress Annual Convention

Read Less

Doctoral Theses Guided

2019

Isolation and charcterization of genetic variants of betacasein protein (A1/A2) and study their impact on early precipitation of osteoporosis

Sushil Kumar Yadav, Birla Institute of Technology and Science Pilani

2017

Behavioral and neuro-pharmacological screenig of potential serotonergic modulators for depression co-morbid with obesity

Yeshwant Vijay Kurhe, Birla Institute of Technology and Science Pilani

2016

Novel Neuro-Pharmacological Agents for the Treatment of Depression, Anxiety, Cognitive dysfunction and Cancer Chemo- Therapy Induced Emesis: Design synthesis and Screening af Potential Serotonergic Modulators

Arghya K Dhar, Birla Institute of Technology and Science, Pilani

Read More
2019

Isolation and charcterization of genetic variants of betacasein protein (A1/A2) and study their impact on early precipitation of osteoporosis

Sushil Kumar Yadav, Birla Institute of Technology and Science Pilani

2017

Behavioral and neuro-pharmacological screenig of potential serotonergic modulators for depression co-morbid with obesity

Yeshwant Vijay Kurhe, Birla Institute of Technology and Science Pilani

2016

Novel Neuro-Pharmacological Agents for the Treatment of Depression, Anxiety, Cognitive dysfunction and Cancer Chemo- Therapy Induced Emesis: Design synthesis and Screening af Potential Serotonergic Modulators

Arghya K Dhar, Birla Institute of Technology and Science, Pilani

2016

Behavioral and neuro-pharmacological screening of potential serotonergic ligands for the management of depression and anxiety co-morbid with type-1 diabetes mellitus

Deepali Gupta, Birla Institute of Technology and Science Pilani

2016

Design synthesis and screening of potential anti- malarial agents

Sourabh Mundra, Birla Institute of Technology and Science Pilani

2015

Behavioural and Neuropharmacological Screening of Potential Serotonergic Ligands for Co-morbid Depression, Anxiety and Related Disorders such as Cancer Chemotherapy Induced Nausea and Vomiting (CINV)

Shvetank Bhatt, Birla Institute of Technology and Science, Pilani

2015

Design, Synthesis and Pharmacological Evaluation of Novel Phosphodiesterase-IV inhibitors for their Anti-depressant and Anxiolytic Potential

Muthu V. Sudali, Birla Institute of Technology and Science, Pilani

2015

Behavioral and Neuropharmacological Screening of Phosphodiesterase4 (PDE4) Inhibitors for Anti-depressant and Anxiolytic Potential

Ankur Jindal, Birla Institute of Technology and Science, Pilani

2012

Novel Quinoxaline Carboxamides: Design, Synthesis And Neuro-Pharmacological Evaluation as Anti-depressants, Anxiolytic And in the Management of Cancer Chemotherapy-Induced Nausea and Vomiting

T. Devadoss, Birla Institute of Technology and Science, Pilani

2011

Neurobehavioural and Neurochemical Evaluation of Selected Monoaminergic Modulators in Animal Models of Comorbid Depression and Anxiety

Dilip Kumar Pandey, Birla Institute of Technology and Science, Pilani

2008

Behavioural Neuropharmacological Studies of Selected Serotonin Type-3 Receptor Antagonists as Potential Anti-depressants

RajKumar R, Birla Institute of Technology and Science, Pilani

2005

Design Synthesis and pharmacological evaluation of novel serotonergic 5HT3 receptor antagonist as potential agents for the treatment of cancer chemotherapy induced emesis

Venkatesha Perumal R, Birla Institute of Technology and Science, Pilani

Read Less

Membership In Professional Bodies

2010

Indian Pharmacological Society

Life Time

2010

Association of Pharmaceutial Teachers of India

Life Time

2010

Indian Pharmacological Society

Life Time

2010

Association of Pharmaceutial Teachers of India

Life Time

Read Less

Research Projects

Design and synthesis development of new class of anti-malarial agents

Funding Agency : DBT sponsored Indo-Canadian Joint Consortium (Phase-II)

Design and synthesis development of new class of anti-malarial agents

Funding Agency : DBT sponsored Indo-Canadian Joint Consortium (Phase-I)

Synthesis and pharmacological evaluation of novel phosphodiesterase 4 inhibitors for their anti-depressant and anxiolytic potential

Funding Agency : DBT

Read More

Design and synthesis development of new class of anti-malarial agents

Funding Agency : DBT sponsored Indo-Canadian Joint Consortium (Phase-II)

Design and synthesis development of new class of anti-malarial agents

Funding Agency : DBT sponsored Indo-Canadian Joint Consortium (Phase-I)

Synthesis and pharmacological evaluation of novel phosphodiesterase 4 inhibitors for their anti-depressant and anxiolytic potential

Funding Agency : DBT

Novel Neuro - Pharmacological Agents for the Treatment of Depression, Anxiety, Cognitive Dysfunction and CCIE: Design, Synthesis and Screening of Potential Serotonergic Modulators

Funding Agency : ICMR

Read Less

Patents







Read Less